MHARG, Department of Health Sciences, University of York, York, United Kingdom; Institute of Health Informatics, University College London, London, United Kingdom; Clinical Centre of Excellence for Body, Mind and Health, GGz Breburg, Tilburg, the Netherlands.
MHARG, Department of Health Sciences, University of York, York, United Kingdom.
J Psychosom Res. 2023 Oct;173:111460. doi: 10.1016/j.jpsychores.2023.111460. Epub 2023 Aug 12.
Somatic Symptom and Related Disorders(SSRD) are characterised by an intense focus on somatic symptoms that causes significant distress. A self-report scale developed to assess distress as symptom-related thoughts, feelings, and behaviors (SSD-12) has proved to be a reliable, valid and time-efficient measure for Somatic Symptom Disorder(SSD). This cross-sectional study aimed to compare the SSD-12 with psychiatric assessment as gold standard in a Dutch clinical population for SSRD compared to other widely used measures.
Data were collected from adult patients visiting a specialised mental health outpatient clinic for SSRD in the Netherlands, between 2015 and 2017. Analyses included item evaluation, scale reliability, construct validity, diagnostic utility and cut points. Performance of SSD-12, Whiteley Index(WI) and PHQ-15 were compared in Receiver operating characteristics (ROC) curves.
223 patients with SSD, Functional Neurological Disorder, Illness Anxiety(IA) and no SSRD participated. SSD-12 items were normally distributed; total scores correlated with measures of health anxiety, anxiety and depression. The optimal cut point for the SSD-12 was 22 (sensitivity 75.9%, specificity 63.6%). The ROC area under the curve for SSD-12 was 0.75 compared to 0.68 for the WI and 0.65 for the PHQ-15. Combinations of those questionnaires did not yield better results than for the SSD-12 alone.
The SSD-12 alone outperformed the WI and PHQ-15 and combined scales in effectively distinguishing SSRDs from other mental disorders. This may suggest that distress is a more accurate indicator of SSRD than earlier diagnostic criteria as operationalised in the WI and PHQ-15.
躯体症状及相关障碍(SSRD)的特点是对躯体症状的强烈关注,导致明显的痛苦。为了评估与症状相关的想法、感觉和行为引起的痛苦,开发了一种自我报告量表(SSD-12),该量表已被证明是躯体症状障碍(SSD)可靠、有效和省时的测量方法。本横断面研究旨在比较 SSD-12 与精神病学评估作为金标准,以评估荷兰临床 SSRD 人群与其他广泛使用的测量方法相比的躯体症状及相关障碍。
2015 年至 2017 年期间,从荷兰专门的精神科门诊 SSRD 患者中收集数据。分析包括项目评估、量表信度、结构效度、诊断效用和切点。SSD-12、Whiteley 指数(WI)和 PHQ-15 的性能在接受者操作特征(ROC)曲线中进行比较。
223 名 SSD、功能性神经障碍、疾病焦虑(IA)和无 SSRD 患者参与了研究。SSD-12 项目呈正态分布;总分与健康焦虑、焦虑和抑郁测量值相关。SSD-12 的最佳截断值为 22(灵敏度 75.9%,特异性 63.6%)。SSD-12 的 ROC 曲线下面积为 0.75,而 WI 为 0.68,PHQ-15 为 0.65。这些问卷的组合并没有比 SSD-12 单独使用产生更好的结果。
SSD-12 单独使用优于 WI 和 PHQ-15 以及组合量表,能有效区分 SSRD 与其他精神障碍。这可能表明,与 WI 和 PHQ-15 中所操作化的早期诊断标准相比,痛苦是 SSRD 的更准确指标。